Surgical Science Sweden AB (publ): Annual Report 2025
- Kursreaktion
- +43,3 %
- Sedan publicering
- RVOL vid samma tid
- Saknas
- 18 sep.
- RVOL mot heldag
- 0,4×
- 18 sep. · 20 dagars snitt
Aktiekurs
Mätpunkter & underlag
Aktien 18 sep.
- Senaste kurs
- 49,2 SEK
18 sep. 17:30
- Föregående stängning
- 48,28 SEK
2026-09-17
- Handlad volym
- 94 233 aktier
18 sep. 17:29
- Jämförelseunderlag
- 0 handelsdagar · preliminärt
18 sep. mot föregående stängning
+1,9 %RVOL vid samma tid jämför den kumulativa volymen med samma klockslag tidigare handelsdagar. RVOL mot heldag jämför med snittet för 20 hela handelsdagar. Det är bolagets handel, inte volym orsakad av nyheten.
Handelsdagen ovan är senare än nyhetens första börssession.
Leverantörens stängningskurs; justering för bolagshändelser är inte verifierad.
Läs hela källtexten
Surgical Science has today published its Annual Report for 2025. The document is attached to this press release and is also available at www.surgicalscience.com. Printed copies are sent to shareholders who so request and state their postal address. Gothenburg, Sweden, April 15, 2026 Surgical Science Sweden AB (publ) The Annual Report is available in the attachment or via https://surgicalscience.com/investor-relations/#press-releases https://surgicalscience.com/aktien/financial-report (https://surgicalscience.com/investor-relations/#financial-report) For further information, please contact: ------------------------------------------------------------------------------ Tom Englund, CEO Telephone: +46-70-916 16 81 E-mail: tom.englund@surgicalscience.com Anna Ahlberg, CFO Telephone: +46-70-855 38 35 E-mail: anna.ahlberg@surgicalscience.com About Surgical Science Sweden AB (publ) ------------------------------------------------------------------------------ Surgical Science is a global leader in evidence-based medical simulation. The company’s virtual reality simulators and customized training solutions enable surgeons and healthcare professionals to practice and improve their skills outside the operating room - enhancing patient safety and clinical outcomes. Also, Surgical Science partners with medical technology and robotics companies to integrate tailor-made simulation technology into their devices, helping them accelerate innovation and gain a competitive edge. Surgical Science has approximately 310 employees. The company is headquartered in Gothenburg, Sweden, and has operations in Tel Aviv, Israel; Stockholm, Sweden; Cleveland, US; and Cardiff, UK. Through sales offices in these markets and in China, as well as a global network of distributors, Surgical Science maintains a presence in most markets. Shares in Surgical Science Sweden AB (publ) are traded on Nasdaq First North Growth Market, Stockholm, Sweden. Certified Adviser is DNB Carnegie Investment Bank AB. Attachments ------------------------------------------------------------------------------ SuS AR25 EN (https://storage.mfn.se/cdb09013-8d30-4cb7-bbac-6dc83723365a/sus-ar25-en.pdf)
Källor & underlag